Skip to main content
. 2023 Jul 13;77(12):1676–1686. doi: 10.1093/cid/ciad419

Table 3.

Uni- and Multivariable Regression Results Comorbidities Versus Presence of Plaque

Any Coronary Plaque Univariable Model 1 Model 2 Model 3
OR 95% CI P Value OR 95%CI P Value OR 95% CI P Value OR 95% CI P Value
PCAT density (per 10 HU) 1.30 1.13–1.50 <.001 1.26 1.09–1.47 .002 1.38 1.18–1.62 <.001 1.44 1.22–1.70 <.001
Age, y 1.10 1.07–1.13 <.001
Sex (male) 2.18 1.34–3.56 .002
Race
 White ref.
 Black or African American 0.69 .46–1.03 .066
 Asian 1.61 .39–6.72 .513
 Other 0.98 .56–1.70 .941
ASCVD, % 1.16 1.10–1.22 <.001 1.14 1.08–1.21 <.001
BMI, kg/m2 1.01 .97–1.04 .619 1.01 .97–1.04 .772 1.02 .98–1.06 .272
Substance abuse 1.26 .93–1.72 .134 1.20 .87–1.65 .265 1.23 .87–1.72 .237
Smoking (current) 1.27 .84–1.92 .259
MCP-1, pg/mL 1.09 .99–1.20 .066 1.06 .96–1.17 .259
IL-6, pg/mL 1.05 1.00–1.11 .048 1.06 1.00–1.12 .041
LpPLA2, ng/mL 1.19 1.10–1.28 <.001 1.15 1.06–1.25 .001
oxLDL, mU/L 1.09 .99–1.20 .090 1.13 1.02–1.25 .021
hsCRPm mg/L 1.02 .98–1.07 .342 1.03 .99–1.08 .179

P values were obtained with logistic regression modelling.

Abbreviations: ASCVD, atherosclerotic cardiovascular disease; BMI, body mass index; CI, confidence interval; hsCRP, high-sensitivity C-reactive protein; HU, Hounsfield unit; IL-6, interleukin 6; LpPLA2, lipoprotein-associated phospholipase A2; MCP-1, monocyte chemoattractant protein 1; OR, odds ratio; oxLDL, oxidized low-density lipoprotein; PCAT, pericoronary adipose tissue.